Dental therapeutic systems

Recent Patents on Drug Delivery and Formulation

Volumn 2, Issue 1, 2008, Pages 58-67

  Iqbal, Zeenat ^a   Jain, Nilu ^a   Jain, Gaurav K ^a   Talegaonkar, Sushama ^a   Ahuja, Alka ^a   Khar, Roop K ^a   Ahmad, Farhan J ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Dental fibers; Dental gels; Intrapocket drug delivery; Periodontal local delivery systems; Periodontitis

Indexed keywords

AMPICILLIN; ANISE OIL; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARESTIN; ATRIDOX; BACITRACIN; BENZOYL METRONIDAZOLE; CAMPHOR; CHITOSAN; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CITRONELLAL; CLOVE OIL; DENTOMYCIN; DICLOFENAC; DOXYCYCLINE; ERYTHROMYCIN; EUCALYPTUS OIL; LIDOCAINE; METRONIDAZOLE; MICROSPHERE; MINOCYCLINE; NANOPARTICLE; NANOSPHERE; PEPPERMINT OIL; PERIO CHIP; POLYACRYLIC ACID; POLYMER; TETRACYCLINE; TOOTHPASTE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BIODEGRADABLE IMPLANT; CHEWING GUM; CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; DENTAL CARE; DENTAL ETCHING; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG USE; EMULSION; ENCAPSULATION; GEL; GINGIVITIS; HUMAN; LOW DRUG DOSE; LOZENGE; MICROCAPSULE; MOUTH HYGIENE; MOUTH PAIN; MOUTH SCALING; MOUTHWASH; OINTMENT; PATENT; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW; SUSTAINED RELEASE FORMULATION; TASTE DISORDER;

ADHESIVENESS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GINGIVAL CREVICULAR FLUID; HUMANS; MICROBIAL SENSITIVITY TESTS; PATENTS AS TOPIC; PERIODONTAL DISEASES; PERIODONTAL POCKET; UNITED STATES;

EID: 42249112685     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221108783331366     Document Type: Review

References (83)

1. Genco RJ, Evans RT, Ellison SA. Review of dental research in microbiology with emphasis on periodontal research. J Am Dent Ass 1969; 78: 1016-1023.
2. Slots J. Subgingival microflora and periodontal disease. J Clin Periodontol 1979; 6: 351-354.
3. Carranza AF, Odont J. Periodontal pathology. In: Glickman, AWL ed. Clinical Periodontology, 8th edn. Pennsylvania: WB Saunders Co, 350-351.
4. Holen S. Letter: periodontal health after destructive periodontal disease. J Periodontol 1975; 46: 570.
5. Slots J, van-Winkelhoff AJ. Antimicrobial therapy in periodontitis. J California Dent Assoc 1993; 21: 51-54.
6. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2002; 28: 106-176.
7. Sakellari D, Goodson JM, Kolokotronis, A, Konstantinidis A. Concentration of three tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 2000; 27: 53-60.
8. Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994; 13: 1-22.
9. Guenchidi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres. Eur J Pharm Biopharm 2002; 53: 233-239.
10. Rudnic EM, Schwartz JD. Oral solid dosage forms. In: A. R. Gennaro (Ed.), Remington: The science and practice of pharmacy, 20th eds 2000; 858-859.
11. Barth, J.B.: US4132772 (1979).
12. Turner, R.E.: US5906810 (1999).
13. Simone, A.J., Hefferren, J.J., Hand, M.S., Huber, G.: US5296209 (1994).
14. Lee, W.H.: USS437872 (1995).
15. Lynch, D.M., Appelbaum, B.: US4855128 (1989).
16. Michael, D.W., Berry, G., Upson, J.G.: US5939080 (1999).
17. Vernon, P.G.: US5976506 (1999).
18. Lee, R.C.: US5470568 (1995).
19. Lee, R.C.: US5605687 (1997).
20. Hunter, R.L., Emanuele, R.M., Carpenter, R.H.: US5494660 (1996).
21. Cutler, E.T.: US5900230 (1999).
22. Cloonan, R.A., Towle, L.E.: US20016224376 (2001).
23. Libanati, C., Miller, J.G., Kempske, S.J.: US20056896876 (2005).
24. Zapf, J.T., Fultz, W.C, Liu, S.T., Wozniak, M.E.: US20077166271 (2007).
25. Mody, S.S.B., Mody, P.D., Doshi, M.M.: US20006017516 (2000).
26. Doshi, M.M., Joshi, M.D., Mehts, B.P.: US20026365131-(2002).
27. Pedrazzoli V, Kilian M, Karring T. Comparable clinical and microbiological effects of topical subgigival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis. J Clin Periodontol 1992; 19: 715-722.
28. Rosenbaum, M., Richlin, M., Braverman, A.J.: USS766012 (1998).
29. Sub, B.I.: US5395728 (1995).
30. Combe, E.C., Warford III, J.H., Warford II, J.H.: US20026342204 (2002).
31. Dam, A., Verbave, M., Ross, J.: US20026494716 (2002).
32. Jia, W., Jin, S.: US20046753001 (2004).
33. Galli, G.: US20046689341 (2004).
34. Schaeffer, H.A.: US4528180 (1985).
35. Schaeffer, H.A.: US4687663 (1987).
36. Schaeffer, H.A.: US4849213 (1989).
37. Pellico, M.A.: US20067060256 (2006).
38. Banerjee, A., Friedman, J.: US20056908607 (2005).
39. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline containing fibers for controlled delivery to periodontal pocket. J Periodontol 1983; 54:575-579.
40. Coventry J, Newman HN. Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation. J Clin Periodontol 1982; 9:129-133.
41. Medlicott NJ, Rathbone MJ, Tucker IG, Holborow DW. Delivery systems for the administration of the drugs to the periodontal pocket. Adv Drug Deliv Rev 1994; 13:181-203.
42. Wehrli, J.M.: US20026475471 (2002).
43. Myers, T.D.: US20006019605 (2000).
44. Karmaker, A., Prasad, A.: US20026381989 (2002).
45. Sagel, P.A., Dirksing, R.S., Rohman, F.J., Majeti, S., Reno, E.A.: US20006096328 (2000).
46. Weir, C.D.: US20036619956 (2003).
47. Soskolne Wa, Freidman M. Intraperiodontal pocket drug delivery systems. In: Rathbone SJ, Oral Mucosal Drug Delivery. New York, Marcel Dekker. 1994; 360.
48. Addy M, Rawle L, Handley R, Newman HN, Coventry JF. The development and in vitro evaluation of acrylic strips and dialysis tubing for local drug delivery. J Periodontol 1982; 53: 693-699.
49. Baker RW, Krisko EA, Kochinke F. A controlled release drug delivery system for periodontal pocket. International Symposium on controlled Release Bioactive Materials USA. Controlled Release Society 1988, 238a-238b.
50. Larsen T. in vitro Release of doxycycline from bioabsorbable materials and acrylic strips. J Periodontol 1990; 61: 30-34.
51. Collins AE, Desay PB, MacCarthy DJ, Shanely DB. Evaluation of controlled release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodontal diseases. Int J Pharm 1989; 51: 103-114.
52. Minabe M, Takeuchi K, Tomomatsu E, Hori T, Umemoto T. Clinical effects of local application of collagen film immobilized tetracycline. J Clin Periodontol 1989; 16: 291-294.
53. Addy M, Langeroudi M. Comparison of the immediate effects on the subgingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline, J Clin Periodontol 1984; 11: 379-386.
54. Chung, C.P.: US5599553 (1997).
55. Zyck, D.J., Dzija, M.R., Chapdelaine, A.H.: US20046740332 (2004).
56. Leung, S.H.S., Leone, R.S., Kumar, L.D., Kulkarni, N., Sorg, A.F.: US20056923981 (2005).
57. Needleman IG, Smalcs FC. in vitro Assessment for bioadhesion for periodontal and buccal delivery. Biomaterials 1995; 16: 617-624.
58. Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and mechanical characterization of bioadhsive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 1996; 13: 1734-1738.
59. Needleman IG, Martin GP, Smales FC. Charecterization of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol 1998; 25: 74-87.
60. Robinson, J.R.: US5225196 (1993).
61. Hansen, J., Nielsen, L.S., Norling, T.: US5955502 (1999).
62. Friedman, D., Schwarz, J., Amselem, S.: US5993846 (1999).
63. Nayak, S.: US5989535 (1999).
64. Lawter, J.R., Lanzilotti, M.G.: US5500228 (1996).
65. McGinity JW, Martin A, Cuff GW, Combs AB. Influences of matrixes on nylon encapsulation pharmaceuticals. J Pharm Sci 1981; 70: 372-375.
66. Cuff GW, Comb AB, McGinity JW. Effect of formulation factors on the matrix PH of nylon microcapsules. J. Microencapsulation 1984; 1: 27-32.
67. Nuwayser, E. S.: US5648097 (1997).
68. Masterman, T.C., Spencer, J.L.: US6007795 (1999).
69. Chung, C.P., Lee, S.J.: US5855904 (1999).
70. Howell TH, Reddy MS, Weber HP, et al. Sulfadiazines reduce gingivitis and plaque formation in beagle dogs. J Clin Periodontol 1990; 17: 734-737.
71. Howell TH, Reddy MS, Weber HP, et al. Sulfadiazines prevent plaqua formation and gingivitis in beagles. J Periodontol Res 1990; 25: 197-200.
72. Roberts, F.D., Friden, P.M., Spacciapoli, P., Nelson, E.: US20006153210 (2000).
73. Lee, J.Y., Seo, M.H., Choi, I.J., Kim, J.H., Pai, C.M.: US20016193994 (2001).
74. Lages, R., Aickele, F., Loges, H., Machinek, A.: US20036506368 (2003).
75. Shefer, A., Shefer, S.D.: US20036589562 (2003).
76. Shefer, A., Shefer, S.D.: US20036565873 (2003).
77. Pieczenik, G.: US5560379 (1996).
78. Jacobs, A.J., Schwendeman, S.: US5924863 (1999).
79. Halberstad, C.: US20006034068 (2000).
80. Lynch, E., Schemmer, J.: US20077198489 (2007).
81. Jia, W., Alpert, B.: US20077204875 (2007).
82. Basara, M.: US20046830757 (2004).
83. Barat R, Srinatha A, Pandit JK, et al. Niridazole biodegradable inserts for local long-term treatment of periodontitis: possible new life for an orphan. Drug Deliv 2006; 13: 365-373.